United States · FDA National Drug Code directory
Vraylar
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61874-130_ef3db4f6-9b04-4ffe-b72e-7ab3ceccb224
- Product NDC
- 61874-130
- Form
- CAPSULE, GELATIN COATED
- Composition / generic term
- cariprazine
- Labeler
- Allergan, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20150917
- Source listing expiry
- 20271231
Source-listed ingredients
- CARIPRAZINE — 3 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 CAPSULE, GELATIN COATED in 1 BLISTER PACK (61874-130-07) · 61874-130-07
- 2 BLISTER PACK in 1 CARTON (61874-130-20) / 10 CAPSULE, GELATIN COATED in 1 BLISTER PACK (61874-130-11) · 61874-130-20
- 30 CAPSULE, GELATIN COATED in 1 BOTTLE (61874-130-30) · 61874-130-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →